Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users

Background:Increased natural killer (NK) activation has been associated with resistance to HIV-1 infection in several cohorts of HIV-1 exposed, uninfected individuals. Inheritance of protective NK receptor alleles (KIR3DS1 and KIR3DL1high) has also been observed in a subset of HIV-1 exposed, uninfected individuals. However, the exact mechanism contributing to NK activation in HIV-1 exposed, uninfected intravenous drug users (EU-IDU) remains to be elucidated. Objective:We investigated the role of both host genotype and pathogen-induced dendritic cell modulation of NK activation during high-risk activity in a cohort of 15 EU-IDU individuals and 15 control, uninfected donors from Philadelphia. Design:We assessed the activation status of NK cells and dendritic cells by flow cytometry and utilized functional assays of NK-DC cross-talk to characterize the innate immune compartment in EU-IDU individuals. Results:As previously reported, NK cell activation (CD69) and/or degranulation (CD107a) was significantly increased in EU-IDU individuals compared with control uninfected donors (P = 0.0056, n = 13). Genotypic analysis indicated that the frequency of protective KIR (KIR3DS1) and HLA-Bw4*80I ligands was not enriched in our cohort of EU-IDU individuals. Rather, plasmacytoid dendritic cells (PDC) from EU-IDU exhibited heightened maturation (CD83) compared with control uninfected donors (P = 0.0011, n = 12). When stimulated in vitro, both PDCs and NK cells from EU-IDU individuals maintained strong effector cell function and did not exhibit signs of exhaustion. Conclusion:Increased maturation of PDCs is associated with heightened NK activation in EU-IDU individuals suggesting that both members of the innate compartment may contribute to resistance from HIV-1 infection in EU-IDU.

[1]  Chyvette T. Williams,et al.  Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis. , 2010, American journal of public health.

[2]  Theresa M. Ames,et al.  Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.

[3]  E. Matsui,et al.  Cutting Edge: Unusual NK Cell Responses to HIV-1 Peptides Are Associated With Protection Against Maternal-Infant Transmission of HIV-1 , 2009, Pediatrics.

[4]  L. Montaner,et al.  Retention of viability, cytotoxicity, and response to IL‐2, IL‐15, or IFN‐α by human NK cells after CD107a degranulation , 2009, Journal of leukocyte biology.

[5]  Lisa M. Lee,et al.  Estimation of HIV incidence in the United States. , 2008, JAMA.

[6]  J. Routy,et al.  A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection , 2008, AIDS.

[7]  J. Routy,et al.  Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals , 2008, AIDS.

[8]  M. Carrington,et al.  KIR locus polymorphisms: genotyping and disease association analysis. , 2008, Methods in molecular biology.

[9]  M. Carrington,et al.  KIR locus polymorphisms: genotyping and disease association analysis. , 2008, Methods in molecular biology.

[10]  S. Friedman,et al.  HIV Prevalence Rates among Injection Drug Users in 96 Large US Metropolitan Areas, 1992–2002 , 2008, Journal of Urban Health.

[11]  Jakob Michaëlsson,et al.  Natural Killer Cells in Perinatally HIV-1-Infected Children Exhibit Less Degranulation Compared to HIV-1-Exposed Uninfected Children and Their Expression of KIR2DL3, NKG2C, and NKp46 Correlates with Disease Severity1 , 2007, The Journal of Immunology.

[12]  L. Montaner,et al.  NK Cell Lysis of HIV-1-Infected Autologous CD4 Primary T Cells: Requirement for IFN-Mediated NK Activation by Plasmacytoid Dendritic Cells1 , 2007, The Journal of Immunology.

[13]  D. Altmann,et al.  Natural killer cells, killer immunoglobulin‐like receptors and human leucocyte antigen class I in disease , 2007, Clinical and experimental immunology.

[14]  Amalio Telenti,et al.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.

[15]  D. Scott‐Algara,et al.  Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. , 2007, Blood.

[16]  William M. Lee,et al.  Differential dysfunction in dendritic cell subsets during chronic HCV infection. , 2007, Clinical immunology.

[17]  K. Ugen,et al.  Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy , 2006, Springer Seminars in Immunopathology.

[18]  Todd M. Allen,et al.  HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 , 2006, PLoS medicine.

[19]  W. Ho,et al.  Drug abuse, innate immunity and hepatitis C virus , 2006, Reviews in medical virology.

[20]  C. Chougnet,et al.  Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. , 2006, Clinical immunology.

[21]  R. Hienz,et al.  Morphine Withdrawal Dramatically Reduces Lymphocytes in Morphine-Dependent Macaques , 2006, Journal of Neuroimmune Pharmacology.

[22]  N. Lukacs,et al.  Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus , 2006, The Journal of experimental medicine.

[23]  D. Lysle,et al.  Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell , 2006, Journal of Neuroimmunology.

[24]  Dennis P. Culhane,et al.  Homelessness and HIV risk behaviors among injection drug users , 2004, Journal of Urban Health.

[25]  J. Schroeder,et al.  TLR9- and FcεRI-Mediated Responses Oppose One Another in Plasmacytoid Dendritic Cells by Down-Regulating Receptor Expression1 , 2005, The Journal of Immunology.

[26]  M. Müller-Trutwin,et al.  Role for plasmacytoid dendritic cells in anti‐HIV innate immunity , 2005, Immunology and cell biology.

[27]  R. Pauwels,et al.  Pulmonary dendritic cells. , 2005, American journal of respiratory and critical care medicine.

[28]  N. Hayashi,et al.  Impaired Function of Dendritic Cells Circulating in Patients Infected with Hepatitis C Virus Who Have Persistently Normal Alanine Aminotransferase Levels , 2005, Intervirology.

[29]  C. Boileau,et al.  A Prognostic Model for HIV Seroconversion Among Injection Drug Users as a Tool for Stratification in Clinical Trials , 2005, Journal of acquired immune deficiency syndromes.

[30]  K. Matsushima,et al.  Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs , 2005, The Journal of experimental medicine.

[31]  M. Brunetto,et al.  Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. , 2005, Journal of hepatology.

[32]  H. Rosen,et al.  Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease , 2004, Hepatology.

[33]  D. Scott‐Algara,et al.  Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users 1 , 2003, The Journal of Immunology.

[34]  T. Giese,et al.  Activation with CpG-A and CpG-B Oligonucleotides Reveals Two Distinct Regulatory Pathways of Type I IFN Synthesis in Human Plasmacytoid Dendritic Cells 1 , 2003, The Journal of Immunology.

[35]  Keith Hoots,et al.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.

[36]  V. Hornung,et al.  Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells , 2001 .

[37]  R. Biassoni,et al.  Human natural killer cell receptors and co‐receptors , 2001, Immunological reviews.

[38]  V. Hornung,et al.  Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. , 2001, European journal of immunology.

[39]  Eric O Long,et al.  Killer cell inhibitory receptors: diversity, specificity, and function , 1997, Immunological reviews.

[40]  P. Fitzgerald-Bocarsly,et al.  Interferon‐α ‐dependent and ‐independent participation of accessory cells in natural killer cell‐mediated lysis of HSV‐1‐infected fibroblasts , 1992, Journal of leukocyte biology.

[41]  B. Rouveix.  Opiates and immune function. Consequences on infectious diseases with special reference to AIDS. , 1992, Therapie.

[42]  M. Feldman,et al.  Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji. , 1989, Journal of immunology.

[43]  D. Miller,et al.  Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts. , 1987, Journal of immunology.

[44]  G. Trinchieri,et al.  Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts , 1986, The Journal of experimental medicine.

[45]  G. Trinchieri,et al.  A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. , 1985, Natural immunity and cell growth regulation.